{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T16:12:30Z","timestamp":1664381550190},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T00:00:00Z","timestamp":1493337600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00482-017-0218-x","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T08:04:28Z","timestamp":1493366668000},"page":"308-318","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Der Einfluss von Interessenkonflikten auf Leitlinienempfehlungen"],"prefix":"10.1007","volume":"31","author":[{"given":"W.","family":"H\u00e4user","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Petzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nothacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,28]]},"reference":[{"key":"218_CR1","first-page":"468","volume":"99","author":"Arbeitsgemeinschaft wissenschaftlicher Fachgesellschaften AWMF","year":"2006","unstructured":"Arbeitsgemeinschaft wissenschaftlicher Fachgesellschaften AWMF, \u00c4rztliches Zentrum f\u00fcr Qualit\u00e4t in der Medizin (\u00c4ZQ) (2006) Deutsches Instrument zur methodischen Leitlinienbewertung (DELBI). Z\u00a0\u00c4rztl Fortbild Qual Gesundhwes 99:468\u2013492","journal-title":"Z \u00c4rztl Fortbild Qual Gesundhwes"},{"key":"218_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1472-6939-14-19","volume":"14","author":"JB Bindslev","year":"2013","unstructured":"Bindslev JB, Schroll J, G\u00f8tzsche PC, Lundh A (2013) Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study. BMC Med Ethics 14:19","journal-title":"BMC Med Ethics"},{"key":"218_CR3","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1056\/NEJMc0810237","volume":"360","author":"L Cosgrove","year":"2009","unstructured":"Cosgrove L, Bursztajn HJ, Krimsky S (2009) Developing unbiased diagnostic and treatment guidelines in psychiatry. N\u00a0Engl J Med 360:2035\u20132036","journal-title":"N Engl J Med"},{"key":"218_CR4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jep.12244","volume":"20","author":"L Cosgrove","year":"2014","unstructured":"Cosgrove L, Shaughnessy AF, Wheeler EE, Krimsky S, Peters SM, Freeman-Coppadge DJ, Lexchin JR (2014) From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline development. J\u00a0Eval Clin Pract 20:809\u2013812","journal-title":"J Eval Clin Pract"},{"key":"218_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/08989621.2016.1251319","volume":"24","author":"L Cosgrove","year":"2017","unstructured":"Cosgrove L, Krimsky S, Wheeler EE, Peters SM, Brodt M, Shaughnessy AF (2017) Conflict of interest policies and industry relationships of guideline development group members: a cross-sectional study of clinical practice guidelines for depression. Account Res 24:99\u2013115","journal-title":"Account Res"},{"key":"218_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-153-6-201009210-00021","volume":"153","author":"GA Fava","year":"2010","unstructured":"Fava GA (2010) Guidelines and conflicts of interest. Ann Intern Med 153:421\u2013422 (author reply 422)","journal-title":"Ann Intern Med"},{"key":"218_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000442694","volume":"85","author":"GA Fava","year":"2016","unstructured":"Fava GA (2016) The hidden costs of financial conflicts of interest in medicine. Psychother Psychosom 85:65\u201370","journal-title":"Psychother Psychosom"},{"key":"218_CR8","first-page":"Doc14","volume":"6","author":"W H\u00e4user","year":"2008","unstructured":"H\u00e4user W, Arnold B, Eich W, Felde E, Fl\u00fcgge C, Hennigsen P, Herrmann M, K\u00f6llner V, Nutzinger D, Offenb\u00e4cher M, Offenb\u00e4cher M, Schiltenwolf M, Sommer C, Thieme K, Thieme K, Kopp I (2008) Management of fibromyalgia syndrome \u2013 an interdisciplinary evidence-based guideline. Ger Med Sci 6:Doc14","journal-title":"Ger Med Sci"},{"key":"218_CR9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00482-012-1189-6","volume":"26","author":"W H\u00e4user","year":"2012","unstructured":"H\u00e4user W, Wang H, Bernardy K, Kopp I (2012) Methodenreport zur Erstellung der Leitlinie. Schmerz 26:232\u2013246","journal-title":"Schmerz"},{"key":"218_CR10","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","volume":"1","author":"W H\u00e4user","year":"2015","unstructured":"H\u00e4user W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, Walitt B (2015) Fibromyalgia. Nat Rev Dis Primers 1:15022","journal-title":"Nat Rev Dis Primers"},{"key":"218_CR11","volume-title":"Fibromyalgiesyndrom: Definition, Pathophysiologie, Diagnostik und Therapie","author":"Leitlinienwatch","year":"2012","unstructured":"Leitlinienwatch (2012) Fibromyalgiesyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. \n                        https:\/\/www.leitlinienwatch.de\/fibromyalgiesyndrom-definition-pathophysiologie-diagnostik-und-therapie\/\n                        \n                    . Zugegriffen: 23. Mai 2016"},{"key":"218_CR12","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-19842-7","volume-title":"Interessenkonflikte in der Medizin, Hintergr\u00fcnde und L\u00f6sungsm\u00f6glichkeiten","author":"K Lieb","year":"2011","unstructured":"Lieb K, Klemperer D, Ludwig W\u2011D (2011) Interessenkonflikte in der Medizin, Hintergr\u00fcnde und L\u00f6sungsm\u00f6glichkeiten. Springer, Berlin Heidelberg"},{"key":"218_CR13","volume-title":"Das AWMF-Regelwerk Leitlinien","author":"C Muche-Borowski","year":"2012","unstructured":"Muche-Borowski C, Selbmann HK, M\u00fcller W, Nothacker M, Kopp I, f\u00fcr die St\u00e4ndige Kommission \u201eLeitlinien\u201c der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2012) Das AWMF-Regelwerk Leitlinien. \n                        http:\/\/www.awmf.org\/leitlinien\/awmf-regelwerk.html\n                        \n                    . Zugegriffen: 30. Sept 2014"},{"key":"218_CR14","doi-asserted-by":"crossref","first-page":"d5621","DOI":"10.1136\/bmj.d5621","volume":"343","author":"J Neuman","year":"2011","unstructured":"Neuman J, Korenstein D, Ross JS, Keyhani S (2011) Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 343:d5621","journal-title":"BMJ"},{"key":"218_CR15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","volume":"163","author":"HJ Sch\u00fcnemann","year":"2015","unstructured":"Sch\u00fcnemann HJ, Al-Ansary LA, Forland F, Kersten S, Komulainen J, Kopp IB, Macbeth F, Phillips SM, Robbins C, van der Wees P, Qaseem A, Board of Trustees of the Guidelines International Network (2015) Guidelines international network: principles for disclosure of interests and management of conflicts in guidelines. Ann Intern Med 163:548\u2013553","journal-title":"Ann Intern Med"},{"key":"218_CR16","volume-title":"Konsultationsfassung zur Interessenkonfliktregel: R\u00fcckmeldungen. Delegiertenkonferenz der AWMF 30.04.2016","author":"C Spies","year":"2016","unstructured":"Spies C, Kopp I (2016) Konsultationsfassung zur Interessenkonfliktregel: R\u00fcckmeldungen. Delegiertenkonferenz der AWMF 30.04.2016. \n                        http:\/\/www.awmf.org\/fileadmin\/user_upload\/Die_AWMF\/Delegiertenkonferenz\/DK-2016-04\/DK-2016-04_TOP10_Kopp.pdf\n                        \n                    . Zugegriffen: 30. Juni 2016"},{"key":"218_CR17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3899\/jrheum.081180","volume":"36","author":"F Wolfe","year":"2009","unstructured":"Wolfe F (2009) Fibromyalgia wars. J\u00a0Rheumatol 36:671\u2013678","journal-title":"J Rheumatol"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-017-0218-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-017-0218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-017-0218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T05:57:39Z","timestamp":1496210259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-017-0218-x"}},"subtitle":["Eine empirische Studie zur zweiten Aktualisierung der interdisziplin\u00e4ren S3\u2011Leitlinie zum Fibromyalgiesyndrom"],"short-title":[],"issued":{"date-parts":[[2017,4,28]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["218"],"URL":"https:\/\/doi.org\/10.1007\/s00482-017-0218-x","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,28]]}}}